Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
European Radiology
|
August 25, 2016
Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
Francesco Giganti, Sofia Antunes, Annalaura Salerno, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)
Michele Reni, Stefano Cereda, Alessia Rognone, et al.
European Journal of Radiology
|
June 7, 2017
Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology
Francesco Giganti, Paolo Marra, Alessandro Ambrosi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 24, 2015
Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography
Francesco Giganti, Elena Orsenigo, Paolo Giorgio Arcidiacono, et al.
The Lancet. Gastroenterology & Hepatology
|
September 18, 2018
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
Michele Reni, Silvia Zanon, Umberto Peretti, et al.
Gastrointestinal Endoscopy
|
October 2, 2012
Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer
Paolo Giorgio Arcidiacono, Silvia Carrara, Michele Reni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2018
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
Michele Reni, Silvia Zanon, Gianpaolo Balzano, et al.
The Lancet. Oncology
|
June 1, 2005
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Michele Reni, Stefano Cordio, Carlo Milandri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2015
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Michele Reni, Erica Dugnani, Stefano Cereda, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2016
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
Maddalena Migliavacca, Andrea Assanelli, Francesca Ferrua, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
European Radiology
|
August 25, 2016
Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
Francesco Giganti, Sofia Antunes, Annalaura Salerno, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)
Michele Reni, Stefano Cereda, Alessia Rognone, et al.
European Journal of Radiology
|
June 7, 2017
Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology
Francesco Giganti, Paolo Marra, Alessandro Ambrosi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 24, 2015
Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography
Francesco Giganti, Elena Orsenigo, Paolo Giorgio Arcidiacono, et al.
The Lancet. Gastroenterology & Hepatology
|
September 18, 2018
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
Michele Reni, Silvia Zanon, Umberto Peretti, et al.
Gastrointestinal Endoscopy
|
October 2, 2012
Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer
Paolo Giorgio Arcidiacono, Silvia Carrara, Michele Reni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2018
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
Michele Reni, Silvia Zanon, Gianpaolo Balzano, et al.
The Lancet. Oncology
|
June 1, 2005
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Michele Reni, Stefano Cordio, Carlo Milandri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2015
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Michele Reni, Erica Dugnani, Stefano Cereda, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2016
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
Maddalena Migliavacca, Andrea Assanelli, Francesca Ferrua, et al.
Page
of 11